Table 1.
Patients' characteristics.
| Patient number | Gender (M/F) | Age (years) | Reported BDZ dosage at admission |
Antide pressant |
|---|---|---|---|---|
| 1 | M | 38 | LRZ 25 mg/day | Agomelatine |
| CLO 2 mg/day | ||||
| 2 | M | 44 | LRM 75 mg/day | None |
| 3 | F | 42 | LRM 75 mg/day | Duloxetine |
| 4 | F | 55 | ALP 35 mg/day | Escitalopram |
| 5 | F | 47 | CLO 12 mg/day | Mirtazapine |
| 6 | F | 52 | LRM 25 mg/day | Venlafaxine plus agomelatine |
| LRM 12 mg/day | ||||
| DZP 100 mg/day | ||||
| DZP 30 mg/day | ||||
| FLZ 180 mg/day | ||||
| TRZ 1.5 mg/day | ||||
| LRZ 15 mg/day | ||||
| ALP 4 mg/day | ||||
| CLO 12 mg/day | ||||
| 7 | F | 47 | LRM 400 mg/day | Agomelatine |
| DLZ 12 mg/day | ||||
| 8 | F | 37 | LRM 40 mg/day | Agomelatine |
| 9 | M | 36 | LRM 150 mg/day | None |
| 10 | F | 43 | LRZ 50 mg/day | Citalopram |
| 11 | F | 31 | LRM 100 mg/day | Paroxetine |
| 12 | F | 30 | LRM 75 mg/day | Sertraline |
| 13 | M | 38 | ALP 15 mg/day | Escitalopram |
| 14 | M | 32 | LRM 150 mg/day | Citalopram |
ALP, aprazolam; CLO, clonazepam; DLZ, delorazepam; DZP, diazepam; F, female; FLZ, flurazepam; LRM, lormetazepam; LRZ, lorazepam; M, male; TRZ, triazolam.